Investigators showed that ACE2-overexpressing A549 cell-derived microparticles were a potential therapeutic agent against SARS-CoV-2 infection.
[Cellular & Molecular Immunology]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.